Cognitive behavioural therapy for the treatment of depression in people with multiple sclerosis: A systematic review and meta-analysis

BMC Psychiatry

Volumn 14, Issue 1, 2014, Pages

  Hind, Daniel ^a   Cotter, Jack ^b   Thake, Anna ^c   Bradburn, Mike ^a   Cooper, Cindy ^a   Isaac, Claire ^d   House, Allan ^e  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c UNIVERSITY OF HERTFORDSHIRE   (United Kingdom)

^d SHEFFIELD TEACHING HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^e UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

Cognitive behavioural therapy; Depression; Multiple sclerosis; Quality of life; Systematic review

Indexed keywords

ARTICLE; COGNITIVE THERAPY; CONTROLLED CLINICAL TRIAL (TOPIC); DEPRESSION; HUMAN; META ANALYSIS; MULTIPLE SCLEROSIS; PUBLICATION; QUALITY CONTROL; SENSITIVITY ANALYSIS; SYSTEMATIC REVIEW; COMPLICATION; PSYCHOLOGY; TREATMENT OUTCOME;

COGNITIVE THERAPY; DEPRESSION; HUMANS; MULTIPLE SCLEROSIS; TREATMENT OUTCOME;

EID: 84892158063     PISSN: None     EISSN: 1471244X     Source Type: Journal    
DOI: 10.1186/1471-244X-14-5     Document Type: Article

References (74)

1. Confavreux C, Vukusic S. Natural history of multiple sclerosis: a unifying concept. Brain 2006, 129:606-616. 10.1093/brain/awl007, 16415308.
2. Siegert RJ, Abernethy DA. Depression in multiple sclerosis: a review. J Neurol Neurosur Ps 2005, 76:469-475.
3. Galeazzi GM, Ferrari S, Giaroli G, Mackinnon A, Merelli E, Motti L, et al. Psychiatric disorders and depression in multiple sclerosis outpatients: impact of disability and interferon beta therapy. Neurol Sci 2005, 26:255-262. 10.1007/s10072-005-0468-8, 16193252.
4. Patten SB, Beck CA, Williams JV, Barbui C, Metz LM. Major depression in multiple sclerosis: a population-based perspective. Neurology 2003, 61:1524-1527. 10.1212/01.WNL.0000095964.34294.B4, 14663036.
5. Green G, Todd J. 'Restricting choices and limiting independence': social and economic impact of multiple sclerosis upon households by level of disability. Chronic Illn 2008, 4:160-172. 10.1177/1742395307087457, 18796505.
6. Arnett PA, Higginson CI, Voss WD, Bender WI, Wurst JM, Tippin JM. Depression in multiple sclerosis: relationship to working memory capacity. Neuropsychology 1999, 13:546-556.
7. Heesen C, Schulz KH, Fiehler J, Von der MU, Otte C, Jung R, et al. Correlates of cognitive dysfunction in multiple sclerosis. Brain Behav Immun 2010, 24:1148-1155. 10.1016/j.bbi.2010.05.006, 20621641.
8. Pozzilli C, Schweikert B, Ecari U, Oentrich W. Supportive strategies to improve adherence to IFN beta-1b in multiple sclerosis - Çö results of the BetaPlus observational cohort study. J Neurol Sci 2011, 307:120-126. 10.1016/j.jns.2011.04.026, 21636099.
9. Feinstein A. An examination of suicidal intent in patients with multiple sclerosis. Neurology 2002, 59:674-678. 10.1212/WNL.59.5.674, 12221156.
10. Turner AP, Williams RM, Bowen JD, Kivlahan DR, Haselkorn JK. Suicidal ideation in multiple sclerosis. Arch Phys Med Rehabil 2006, 87:1073-1078. 10.1016/j.apmr.2006.04.021, 16876552.
11. D'Alisa S, Miscio G, Baudo S, Simone A, Tesio L, Mauro A. Depression is the main determinant of quality of life in multiple sclerosis: a classification-regression (CART) study. Disabil Rehabil 2006, 28:307-314. 10.1080/09638280500191753, 16492625.
12. Janardhan V, Bakshi R. Quality of life in patients with multiple sclerosis: the impact of fatigue and depression. J Neurol Sci 2002, 205:51-58. 10.1016/S0022-510X(02)00312-X, 12409184.
13. Mitchell AJ, Benito-Leon J, Gonzalez JM, Rivera-Navarro J. Quality of life and its assessment in multiple sclerosis: integrating physical and psychological components of wellbeing. Lancet Neurol 2005, 4:556-566. 10.1016/S1474-4422(05)70166-6, 16109362.
14. Wang JL, Reimer MA, Metz LM, Patten SB. Major depression and quality of life in individuals with multiple sclerosis. Int J Psychiatry Med 2000, 30:309-317.
15. Bakshi R, Czarnecki D, Shaikh ZA, Priore RL, Janardhan V, Kaliszky Z, et al. Brain MRI lesions and atrophy are related to depression in multiple sclerosis. Neuroreport 2000, 11:1153-1158. 10.1097/00001756-200004270-00003, 10817583.
16. Feinstein A, Roy P, Lobaugh N, Feinstein K, O'Connor P, Black S. Structural brain abnormalities in multiple sclerosis patients with major depression. Neurology 2004, 62:586-590. 10.1212/01.WNL.0000110316.12086.0C, 14981175.
17. McCabe MP, McKern S, McDonald E. Coping and psychological adjustment among people with multiple sclerosis. J Psychosom Res 2004, 56:355-361. 10.1016/S0022-3999(03)00132-6, 15046974.
18. Moore P, Hirst C, Harding KE, Clarkson H, Pickersgill TP, Robertson NP. Multiple sclerosis relapses and depression. J Psychosom Res 2012, 73:272-276. 10.1016/j.jpsychores.2012.08.004, 22980532.
19. Feinstein A. Multiple sclerosis and depression. Mult Scler 2011, 17:1276-1281. 10.1177/1352458511417835, 22058085.
20. Goldman Consensus Group The Goldman Consensus statement on depression in multiple sclerosis. Mult Scler 2005, 11:328-337. Goldman Consensus Group.
21. Beck AT. Cognitive therapy and the emotional disorders 1976, Oxford: International Universities Press.
22. Arnett PA, Higginson CI, Voss WD, Randolph JJ, Grandey AA. Relationship between coping, cognitive dysfunction and depression in multiple sclerosis. Clin Neuropsychol 2002, 16:341-355. 10.1076/clin.16.3.341.13852, 12607147.
23. Dennison L, Moss-Morris R, Chalder T. A review of psychological correlates of adjustment in patients with multiple sclerosis. Clin Psychol Rev 2009, 29:141-153. 10.1016/j.cpr.2008.12.001, 19167801.
24. Lynch SG, Kroencke DC, Denney DR. The relationship between disability and depression in multiple sclerosis: the role of uncertainty, coping, and hope. Mult Scler 2001, 7:411-416.
25. Mohr DC, Cox D. Multiple sclerosis: empirical literature for the clinical health psychologist. J Clin Psychol 2001, 57:479-499. 10.1002/jclp.1042, 11255203.
26. Dennison L, Moss-Morris R. Cognitive-behavioral therapy: what benefits can it offer people with multiple sclerosis?. Expert Rev Neurother 2010, 10:1383-1390. 10.1586/ern.10.111, 20819010.
27. Voss WD, Arnett PA, Higginson CI, Randolph JJ, Campos MD, Dyck DG. Contributing factors to depressed mood in multiple sclerosis. Arch Clin Neuropsych 2002, 17:103-115.
28. Thomas PW, Thomas S, Hillier C, Galvin K, Baker R. Psychological interventions for multiple sclerosis. Cochrane Database Syst Rev 2006, 25(1):CD004431.
29. Walker ID, Gonzalez EW. Review of intervention studies on depression in persons with multiple sclerosis. Issues Ment Health Nurs 2007, 28:511-531. 10.1080/01612840701344480, 17613150.
30. Cooper CL, Hind D, Parry GD, Isaac CL, Dimairo M, O'Cathain A, et al. Computerised cognitive behavioural therapy for the treatment of depression in people with multiple sclerosis: external pilot trial. Trials 2011, 12:259. 10.1186/1745-6215-12-259, 3272061, 22168507.
31. Alessandro L, Douglas GA, Jennifer T, Cynthia M, Peter CG, John PAI, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ 2009, 339:b2700. 10.1136/bmj.b2700, 2714672, 19622552.
32. Booth A, Clarke M, Dooley G, Ghersi D, Moher D, Petticrew M, et al. The nuts and bolts of PROSPERO: an international prospective register of systematic reviews. Systematic Reviews 2012, 1:2. 10.1186/2046-4053-1-2, 3348673, 22587842.
33. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983, 33:1444. 10.1212/WNL.33.11.1444, 6685237.
34. Sharrack B, Hughes RA. The Guy's Neurological Disability Scale (GNDS): a new disability measure for multiple sclerosis. Mult Scler 1999, 5:223-233.
35. Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995, 273:408-412. 10.1001/jama.1995.03520290060030, 7823387.
36. Higgins JPT, Green S. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011] 2011, The Cochrane Collaboration, http://www.cochrane-handbook.org.
37. Dwan K, Gamble C, Kolamunnage-Dona R, Mohammed S, Powell C, Williamson PR. Assessing the potential for outcome reporting bias in a review: a tutorial. Trials 2010, 11:52. 10.1186/1745-6215-11-52, 2888817, 20462436.
38. Hobart JC, Riazi A, Lamping D, Fitzpatrick R, Thompson AJ. Improving the evaluation of therapeutic interventions in multiple sclerosis: development of a patient-based measure of outcome. Health Technol Assess 2004, 8(iii):1-48.
39. Cohen J. Statistical power analysis for the behavioral sciences 1988, Hillsdale (NJ): Erlbaum.
40. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986, 7:177-188. 10.1016/0197-2456(86)90046-2, 3802833.
41. Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003, 327:557-560. 10.1136/bmj.327.7414.557, 192859, 12958120.
42. Altman DG, Bland JM. Interaction revisited: the difference between two estimates. BMJ 2003, 326:219. 10.1136/bmj.326.7382.219, 1125071, 12543843.
43. Forman AC, Lincoln NB. Evaluation of an adjustment group for people with multiple sclerosis: a pilot randomized controlled trial. Clin Rehabil 2010, 24:211-221. 10.1177/0269215509343492, 20026575.
44. Lincoln NB, Yuill F, Holmes J, Drummond AE, Constantinescu CS, Armstrong S, et al. Evaluation of an adjustment group for people with multiple sclerosis and low mood: a randomized controlled trial. Mult Scler 2011, 17:1250-1257. 10.1177/1352458511408753, 21613332.
45. Mohr DC, Likosky W, Bertagnolli A, Goodkin DE, Van Der Wende J, Dwyer P, et al. Telephone-administered cognitive-behavioral therapy for the treatment of depressive symptoms in multiple sclerosis. J Consult Clin Psychol 2000, 68:356-361.
46. Mohr DC, Boudewyn AC, Goodkin DE, Bostrom A, Epstein L. Comparative outcomes for individual cognitive-behavior therapy, supportive-expressive group psychotherapy, and sertraline for the treatment of depression in multiple sclerosis. J Consult Clin Psychol 2001, 69:942-949.
47. Mohr DC, Hart SL, Julian L, Catledge C, Honos-Webb L, Vella L, et al. Telephone-administered psychotherapy for depression. Arch Gen Psychiatry 2005, 62:1007-1014. 10.1001/archpsyc.62.9.1007, 16143732.
48. Larcombe NA, Wilson PH. An evaluation of cognitive-behaviour therapy for depression in patients with multiple sclerosis. Br J Psychiatry 1984, 145:366-371. 10.1192/bjp.145.4.366, 6487909.
49. Riazi A, Hobart JC, Lamping DL, Fitzpatrick R, Thompson AJ. Multiple Sclerosis Impact Scale (MSIS-29): reliability and validity in hospital based samples. J Neurol Neurosurg Psychiatry 2002, 73:701-704. 10.1136/jnnp.73.6.701, 1757371, 12438473.
50. Shea B, Grimshaw J, Wells G, Boers M, Andersson N, Hamel C, et al. Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews. BMC Med Res Methodol 2007, 7:10. 10.1186/1471-2288-7-10, 1810543, 17302989.
51. Jamie JK, Kerry MD, Douglas GA, Carrol G, Susanna D, Rebecca S, et al. The impact of outcome reporting bias in randomised controlled trials on a cohort of systematic reviews. BMJ 2010, 340:c365. 10.1136/bmj.c365, 20156912.
52. Stevinson C, Lawlor DA. Searching multiple databases for systematic reviews: added value or diminishing returns?. Complement Ther Med 2004, 12:228-232. 10.1016/j.ctim.2004.09.003, 15649836.
53. Watson RJ, Richardson PH. Identifying randomized controlled trials of cognitive therapy for depression: comparing the efficiency of Embase, Medline and PsycINFO bibliographic databases. Br J Med Psychol 1999, 72:535-542. 10.1348/000711299160220, 10616135.
54. Beckles Z, Glover S, Ashe J, Stockton S, Boynton J, Lai R, et al. Searching CINAHL did not add value to clinical questions posed in NICE guidelines. J Clin Epidemiol 2013, 66:1051-1057. 10.1016/j.jclinepi.2013.04.009, 23835312.
55. Cuijpers P, van Straten A, Bohlmeijer E, Hollon SD, Andersson G. The effects of psychotherapy for adult depression are overestimated: a meta-analysis of study quality and effect size. Psychol Med 2010, 40:211-223. 10.1017/S0033291709006114, 19490745.
56. Morrison A, Polisena J, Husereau D, Moulton K, Clark M, Fiander M, et al. The effect of English-language restriction on systematic review-based meta-analyses: a systematic review of empirical studies. Int J Technol Assess Health Care 2012, 28:138-144. 10.1017/S0266462312000086, 22559755.
57. Hind D, O'Cathain A, Cooper CL, Parry GD, Isaac CL, Rose A, et al. The acceptability of computerised cognitive behavioural therapy for the treatment of depression in people with chronic physical disease: a qualitative study of people with multiple sclerosis. Psychol Health 2010, 25:699-712. 10.1080/08870440902842739, 20204955.
58. Casacalenda N, Perry JC, Looper K. Remission in major depressive disorder: a comparison of pharmacotherapy, psychotherapy, and control conditions. Am J Psychiatry 2002, 159:1354-1360. 10.1176/appi.ajp.159.8.1354, 12153828.
59. Endicott J. Measurement of depression in patients with cancer. Cancer 1984, 53:2243-2248.
60. Mayou R, Hawton K. Psychiatric disorder in the general hospital. Br J Psychiatry 1986, 149:172-190. 10.1192/bjp.149.2.172, 3535978.
61. Kirsch I, Deacon BJ, Huedo-Medina TB, Scoboria A, Moore TJ, Johnson BT. Initial severity and antidepressant benefits: a meta-analysis of data submitted to the food and drug administration. PLoS Med 2008, 5:e45. 10.1371/journal.pmed.0050045, 2253608, 18303940.
62. Bronnum-Hansen H, Stenager E, Nylev SE, Koch-Henriksen N. Suicide among Danes with multiple sclerosis. J Neurol Neurosurg Psychiatry 2005, 76:1457-1459. 10.1136/jnnp.2004.056747, 1739366, 16170097.
63. Stenager EN, Stenager E, Koch-Henriksen N, Bronnum-Hansen H, Hyllested K, Jensen K, et al. Suicide and multiple sclerosis: an epidemiological investigation. J Neurol Neurosurg Psychiatry 1992, 55:542-545. 10.1136/jnnp.55.7.542, 489162, 1640228.
64. Rayner L, Price A, Evans A, Valsraj K, Higginson IJ, Hotopf M. Antidepressants for depression in physically ill people. Cochrane Database Syst Rev 2010, 17(3):CD007503.
65. Simon J, Pilling S, Burbeck R, Goldberg D. Treatment options in moderate and severe depression: decision analysis supporting a clinical guideline. Br J Psychiatry 2006, 189:494-501. 10.1192/bjp.bp.105.014571, 17139032.
66. Clark DM. Implementing NICE guidelines for the psychological treatment of depression and anxiety disorders: the IAPT experience. Int Rev Psychiatry 2011, 23:318-327. 10.3109/09540261.2011.606803, 3212920, 22026487.
67. Dennison L, Moss-Morris R, Yardley L, Kirby S, Chalder T. Change and processes of change within interventions to promote adjustment to multiple sclerosis: Learning from patient experiences. Psychol Health 2013, 1-20.
68. Moss-Morris R, McCrone P, Yardley L, van KK, Wills G, Dennison L. A pilot randomised controlled trial of an Internet-based cognitive behavioural therapy self-management programme (MS Invigor8) for multiple sclerosis fatigue. Behav Res Ther 2012, 50:415-421. 10.1016/j.brat.2012.03.001, 22516321.
69. Pampallona S, Bollini P, Tibaldi G, Kupelnick B, Munizza C. Combined pharmacotherapy and psychological treatment for depression: a systematic review. Arch Gen Psychiatry 2004, 61:714-719. 10.1001/archpsyc.61.7.714, 15237083.
70. Cuijpers P, Dekker J, Hollon SD, Andersson G. Adding psychotherapy to pharmacotherapy in the treatment of depressive disorders in adults: a meta-analysis. J Clin Psychiatry 2009, 70:1219-1229. 10.4088/JCP.09r05021, 19818243.
71. Benito-Leon J, Morales JM, Rivera-Navarro J, Mitchell A. A review about the impact of multiple sclerosis on health-related quality of life. Disabil Rehabil 2003, 25:1291-1303. 10.1080/09638280310001608591, 14617435.
72. Beckner V, Howard I, Vella L, Mohr DC. Telephone-administered psychotherapy for depression in MS patients: moderating role of social support. J Behav Med 2010, 33:47-59. 10.1007/s10865-009-9235-2, 2813530, 19941048.
73. Julian LJ, Mohr DC. Cognitive predictors of response to treatment for depression in multiple sclerosis. J Neuropsychiatry Clin Neurosci 2006, 18:356-363. 10.1176/appi.neuropsych.18.3.356, 16963585.
74. Humphreys I, Drummond AE, Phillips C, Lincoln NB. Cost-effectiveness of an adjustment group for people with multiple sclerosis and low mood: a randomized trial. Clin Rehabil 2013, in press.